PJP is trading at $127.58, down 3.04%, alongside the broad November 5 market selloff, though the specific driver is unclear. - No clear PJP-specific announcement explaining the decline has surfaced. - Recent PJP coverage identifies it as an ETF holding U.S. pharmaceutical companies. - Available reporting says healthcare was among the sectors finding support.